marinabio.com
域名年龄: 15年2个月1天HTTP/1.1 200 OK 服务器:Apache 动作:Accept-Encoding 缓存控制:max-age=1 类型:text/html; charset=ISO-8859-1 Content-Encoding: gzip 访问时间:2014年03月30日 07:32:22 连接:Keep-Alive 设置Cookie:X-Mapping-fjhppofk=E2EC1D3A5D0877C015782A9E603BBDCB; path=/ 文件大小:8184 网站编码:ISO-8859-1 页面编码:utf-8
Contact Us Site Map GO About Marina BiotechResearch & DevelopmentOncology ProgramsPartnershipsInvestorsCareers Advancing RNAi-based therapeutics to transform the treatment of human diseases.     At Marina Biotech we are focused on realizing the potential of RNAi-based therapeutics through the development of multiple broad-based, state-of-the-art drug discovery platforms built upon industry leading expertise in RNA chemistry, microbiology and oligonucleotide delivery. We bring optimal value to our partners, shareholders and ultimately to patients through the discovery and development of RNAi-based therapeutics to treat critical unmet medical needs. Therapeutic Platform We are using multiple RNAi drug discovery engines, tkRNAi and tauRNAi, to develop cutting-edge, first-in-class therapeutics for diverse and commercially valuable disease targets.Learn More Upcoming Clinical Trial Marina Biotech’s first therapeutic candidate, CEQ508 for the treatment of Familial Adenomatous Polyposis (FAP), is now recruiting. Learn More Latest News & Events Marina Biotech, Inc. at Biotech Showcase 2014 Wednesday, January 15, 2014, 4:15 pm PST Register MDRNA has merged with Cequent Pharmaceuticals to become Marina Biotech - focused on accelerating RNAi-based therapeutics. Learn More All Press Releases Share ©2014 Marina Biotech Contact Us| Terms & Conditions built@zoomedia
© 2010 - 2020 网站综合信息查询 同IP网站查询 相关类似网站查询 网站备案查询网站地图 最新查询 最近更新 优秀网站 热门网站 全部网站 同IP查询 备案查询
2025-05-18 06:18, Process in 0.0047 second.